tirzepatide for heart health Weight-loss drug may lower failure deaths Tirzepatide Linked to Better CV
Description
The Delhi High Court has recorded an interim arrangement between Danish pharmaceutical company Novo Nordisk and Torrent Pharmaceuticals Limited in a patent infringement suit concerning semaglutide,...
Mounjaro (tirzepatide) is an FDA-approved injectable drug for type 2 diabetes mellitus, and is commonly used off-label for weight loss
GLP-1RA can also affect the process of skin aging through interaction with advanced glycation end products (AGEs) and RAGE (receptors of AGEs) activation
New research highlights the use of #GLP1 receptor agonists (like semaglutide &
Click to read more!
